AU7615600A - Osteoclast differentiation factor regulatory region - Google Patents

Osteoclast differentiation factor regulatory region

Info

Publication number
AU7615600A
AU7615600A AU76156/00A AU7615600A AU7615600A AU 7615600 A AU7615600 A AU 7615600A AU 76156/00 A AU76156/00 A AU 76156/00A AU 7615600 A AU7615600 A AU 7615600A AU 7615600 A AU7615600 A AU 7615600A
Authority
AU
Australia
Prior art keywords
regulatory region
differentiation factor
osteoclast differentiation
factor regulatory
osteoclast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76156/00A
Inventor
Srinivasan Chandrasekhar
David Lloyd Halladay
Thomas John Martin
Rebecca Ruth Miles
Jude Emeka Onyia
Kannan Thirunavukkarasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU7615600A publication Critical patent/AU7615600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU76156/00A 1999-09-27 2000-09-26 Osteoclast differentiation factor regulatory region Abandoned AU7615600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15578599P 1999-09-27 1999-09-27
US60155785 1999-09-27
PCT/US2000/026407 WO2001023559A1 (en) 1999-09-27 2000-09-26 Osteoclast differentiation factor regulatory region

Publications (1)

Publication Number Publication Date
AU7615600A true AU7615600A (en) 2001-04-30

Family

ID=22556784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76156/00A Abandoned AU7615600A (en) 1999-09-27 2000-09-26 Osteoclast differentiation factor regulatory region

Country Status (2)

Country Link
AU (1) AU7615600A (en)
WO (1) WO2001023559A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
WO2002072842A1 (en) * 2001-03-13 2002-09-19 Oscotec Inc. Transfected cell line which can be used for mass screening of the expression of osteoblast specific transcription factor runx2 and use thereof
WO2005028633A2 (en) 2003-09-17 2005-03-31 Isis Pharmaceuticals, Inc. Modulation of rankl expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO128635A2 (en) * 1997-04-16 2013-07-30 Amgen Inc. Antibody and fragment thereof binding to opgbp and use thereof, use of soluble form of odar and method for identifying a compound reducing the opgbp activity
AU754971B2 (en) * 1998-09-15 2002-11-28 Pharmexa A/S Method for down-regulating osteoprotegerin ligand activity

Also Published As

Publication number Publication date
WO2001023559A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU3350400A (en) Uncalibrated dynamic mechanical system controller
AU3597900A (en) Extended range proportional valve
AU2460101A (en) System for network-based debates
AU2297001A (en) Telestrator system
AU5546000A (en) Compounds
AU6197600A (en) Tactiovisual distance-to-exit exit-finding system
AU6109400A (en) Atomizer system
AU5869900A (en) Uv-imager system
AU7136200A (en) Range measuring system
AU1746401A (en) Compounds
AU2200601A (en) Containers
AU5849300A (en) Proliferation differentiation factor
AU7615600A (en) Osteoclast differentiation factor regulatory region
AU1675800A (en) Lighting system
AU7722100A (en) Self-leveling suspension system
AU5491600A (en) Lifting system
AU2190301A (en) Ranging system
AUPQ067299A0 (en) Atomiser
AU4616699A (en) Hydromagnetotherapy system
AU5119400A (en) Compounds
AU7889400A (en) Rat osteoclast differentiation factor
AU1745401A (en) Hoist system
AU6589300A (en) Variable flange
AU2671800A (en) Personal-assistant system
AU2668000A (en) Bis-styrylbiphenyl compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase